Travel Health Evidence

Conradh

Dhiarrhoea na nAitinn: cad a choinníonn é

Oibríonn prophylaxis níos lú go héifeachtach ná mar a léiríonn na táirgí, agus tá sé níos tábhachtaí a bheith ar an eolas faoi cad atá le déanamh nuair a tharlaíonn sé ná é a chosc.

Updated 3 min read 29 citations Evidence strength 4/5

Laistigh de aerárthach caol le seomraí stórála os cionn agus suíocháin trí shraith
Aykleinman (talk) · Public domain · Wikimedia Commons

Cad a bhaint amach le prophylaxis

Déantar anailísí meitice ar prophylaxis probiotics [1][3][4] agus ar probiotics i gcomparáid le rifaximin [2] a fháil laghdú measartha ar an gcion. Is é measartha an focal oibríochta: is laghdú riosca coibhneasta atá i gceist i gcoinníoll coitianta, ní cosaint.

Ní mholtar prophylaxis antaibheathach go ginearálta do thaistealóirí gnáth. Cuireann sé le frithsheasmhacht, tá fo-iarsmaí aige, agus spreagann sé colún le horgánaigh frithsheasmhaigh a thugann taistilóirí abhaile — costais leibhéal daonra a íocann le haghaidh áisiúlacht leibhéal aonair.

Prophylaxis do dhiarrhoea na n-imreoirí

Bearta bia agus uisce

"Bóthar é, cócaráil é, peel é nó dearmad é" tá sé cuimhneacháin agus ní héifeachtach ach go páirteach — faightear staidéir ar choinneáil a léiríonn go bhfaigheann taistilóirí a leanann na rialacha go dlúth tinn ag rátaí suntasacha, go príomha toisc go dtarlaíonn an nochtadh i gcistineacha nach féidir leo a fheiceáil.

Is iad na bearta a bhfuil an toradh is fearr acu: uisce buidéalaithe nó cóireáilte lena n-áirítear do shúile, ag seachaint oighear nach bhfuil a fhoinse ar eolas, bia te a sheirbheáil te seachas a choinneáil te, agus torthaí a peelann tú féin. Déanann sláinte láimhe roimh ithe níos mó ná an chuid is mó de sheachaint bia.

Nuair nach bhfuil sé ach dhiarrhoea na n-imreoirí

  • Fuil sa stól nó teochtaí ard. Cuardaigh cúram leighis seachas féin-chóireáil.
  • Comharthaí a mhaireann níos faide ná seachtain. Smaoinigh ar chúiseanna parastaí, a theastaíonn cóireáil dhifriúil.
  • Díhiodráitiú trom, go háirithe i leanaí agus taistilóirí níos sine.
  • Comharthaí a thosaíonn tar éis duit filleadh. Inis don chliniceoir cá háit a raibh tú; athraíonn sé an difreáil.
  • Comharthaí leanúnacha tar éis eipeasóid ghéar. Tá IBS iar-ionfhabhtaithe mar thoradh aitheanta agus faoi dhiagnóisiú.

Tá an pointe deireanach sin tuillte: tá mionlach suntasach ag forbairt comharthaí gafa buan tar éis eipeasóid ionfhabhtaithe. Más rud é nach dtagann do ghoile ar ais go gnáth tar éis turas, is feiniméan aitheanta é sin agus ní rud a d'inis tú — féach ar ár suíomh fianaise ghoile-ghréine.

Ceisteanna coitianta

Ar cheart dom probhóitigh a thógáil roimh thaisteal?
Faigheann meiteaanailísí laghduithe measartha [1][2]. Riosca íseal, costas íseal, ionchais ísle.
Ar cheart dom antaibheathaigh a thógáil go coisctheach?
Go ginearálta, ní cheart. Sáraíonn an fhriotaíocht agus na fo-iarsmaí an leas do ghnáththaisteal.
An bhfuil sé sábháilte loperamide a úsáid?
Le haghaidh rialú siomptómaí i mbreoiteacht neamhdhian, tá. Seachain é má tá fiabhras nó fuil sa chac ann.
Cá fhad ar cheart dó mairstean?
Réitíonn formhór na gcásanna laistigh de chúpla lá. Thar seachtain amháin, faigh meastóireacht.
Comhartha cógaisíochta miotail ag dul amach, suite ar bhalla foirgnimh i gConstance
Is é an A dearg ghotach an marc caighdeánach cógaisíochta i dtíortha labhartha na Gearmáine. JoachimKohler-HB · CC BY-SA 4.0 · Wikimedia Commons
An cruthúnas atá taobh thiar den leathanach seo Bar stacked ag taispeáint comhoibriú na 16 foilsithe a luaitear ar an leathanach seo de réir cineál staidéir. 1323meta-analysis (13)review (2)other (3)
16 foilsithe, 2006–2025. Is bunús fair observation é seo. Is féidir leis a bhunú go dtarlaíonn rudaí le chéile; ní féidir leis a shocrú cé acu a chúisíonn leis an gceann eile. Téarma: liosta luaiteanna féin an leathanach seo, thíos.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. Selected laboratory-based biomarkers for assessing vitamin A deficiency in at-risk individuals Gannon BM, Huey SL, Mehta NH, et al. · The Cochrane database of systematic reviews · 2025 · Meta-analysis DOIPubMed 40433851Full text
  2. Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis Raffetin A, Henningsson AJ, Ornstein K, et al. · Infection · 2025 · Meta-analysis DOIPubMed 40246800
  3. Non-pharmacological interventions designed to support carriers of multi-drug-resistant organisms (MDROs): a systematic literature review Gaube S, Pan M, Rath A, et al. · The Journal of hospital infection · 2025 · Systematic review DOIPubMed 40816599
  4. Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review Alharbi BF, Alateek AA · Travel medicine and infectious disease · 2024 · Meta-analysis DOIPubMed 38458507
  5. Orally Ingested Probiotic, Prebiotic, and Synbiotic Interventions as Countermeasures for Gastrointestinal Tract Infections in Nonelderly Adults: A Systematic Review and Meta-Analysis Fagnant HS, Isidean SD, Wilson L, et al. · Advances in nutrition (Bethesda, Md.) · 2023 · Meta-analysis DOIPubMed 36822240Full text
  6. Probiotics and rifaximin for the prevention of travelers' diarrhea: A systematic review and network meta-analysis Fan H, Gao L, Yin Z, et al. · Medicine · 2022 · Meta-analysis DOIPubMed 36221413Full text
  7. Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea Brum JM, Gibb RD, Ramsey DL, et al. · Digestive diseases and sciences · 2021 · Meta-analysis DOIPubMed 32772204Full text
  8. The effectiveness of anti-inflammatory and anti-seizure medication for individuals with single enhancing lesion neurocysticercosis: A meta-analysis and expert group-based consensus recommendations Abraham A, Bustos JA, Carabin H, et al. · PLoS neglected tropical diseases · 2021 · Meta-analysis DOIPubMed 33788843Full text
  9. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact Mouchtouri VA, Christoforidou EP, An der Heiden M, et al. · International journal of environmental research and public health · 2019 · Systematic review DOIPubMed 31766548Full text
  10. Prophylactic efficacy of probiotics on travelers' diarrhea: an adaptive meta-analysis of randomized controlled trials Bae JM · Epidemiology and health · 2018 · Meta-analysis DOIPubMed 30189723Full text
  11. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections Domingues AR, Pires SM, Halasa T, et al. · Epidemiology and infection · 2012 · Meta-analysis DOIPubMed 22214729
  12. Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials Hu Y, Ren J, Zhan M, et al. · Journal of travel medicine · 2012 · Meta-analysis DOIPubMed 23379704
  13. Effectiveness of rifaximin and fluoroquinolones in preventing travelers' diarrhea (TD): a systematic review and meta-analysis Alajbegovic S, Sanders JW, Atherly DE, et al. · Systematic reviews · 2012 · Meta-analysis DOIPubMed 22929178Full text
  14. A meta-analysis of probiotic efficacy for gastrointestinal diseases Ritchie ML, Romanuk TN · PloS one · 2012 · Meta-analysis DOIPubMed 22529959Full text
  15. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients McFarland LV · World journal of gastroenterology · 2010 · Meta-analysis DOIPubMed 20458757Full text
  16. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis Riddle MS, Arnold S, Tribble DR · Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2008 · Meta-analysis DOIPubMed 18781873
  17. Meta-analysis of probiotics for the prevention of traveler's diarrhea McFarland LV · Travel medicine and infectious disease · 2007 · Meta-analysis DOIPubMed 17298915
  18. Probiotics in the prevention of traveler's diarrhea: meta-analysis Takahashi O, Noguchi Y, Omata F, et al. · Journal of clinical gastroenterology · 2007 · Meta-analysis DOIPubMed 17426480
  19. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review Riddle MS, Sanders JW, Putnam SD, et al. · The American journal of tropical medicine and hygiene · 2006 · Meta-analysis PubMed 16687698
  20. Scope and applicability of social-ecological resilience to antimicrobial resistance Wernli D, Søgaard Jørgensen P, Parmley EJ, et al. · The Lancet. Planetary health · 2023 · Review DOIPubMed 37438004
  21. Safe Living Following Solid Organ Transplantation Blair BM · The Surgical clinics of North America · 2019 · Review DOIPubMed 30471739
  22. Travel Medicine Leung DT, LaRocque RC, Ryan ET · Annals of internal medicine · 2018 · Review DOIPubMed 29297035
  23. Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 The Lancet. Infectious diseases · 2026 · Journal article DOIPubMed 41412141
  24. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021 Rautalin I, Volovici V, Stark BA, et al. · JAMA neurology · 2025 · Journal article DOIPubMed 40406922Full text
  25. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092927Full text
  26. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092926Full text
  27. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023 Lancet (London, England) · 2025 · Journal article DOIPubMed 41092928Full text
  28. Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021 The Lancet. Neurology · 2024 · Journal article DOIPubMed 39304265Full text
  29. Foodborne outbreaks, Austria 2007 Much P, Pichler J, Kasper SS, et al. · Wiener klinische Wochenschrift · 2009 · Journal article DOIPubMed 19280130

This page was translated automatically from English. The citations and numbers are unchanged. Read the English original if anything reads oddly. Read the English original